PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today reported financial results for the six months ended June 30, 2015.
Highlights for the first half of 2015 and recent weeks include:
* Acquired CynoGen, Inc. (d/b/a PersonalizeDx) from Prelude Corporation
Help employers find you! Check out all the jobs and post your resume.
